False Negative ECG Device Results May Increase the Risk of Adverse Events in Clinical Oncology Trials

BACKGROUND: Sites participating in clinical trials may not have the expertise and infrastructure to accurately measure cardiac intervals on 12-lead ECGs and rely heavily on the automated ECG device generated results for clinical decision-making. METHODS: Using a dataset of over 260,000 ECGs collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekie, Luc, Kleiman, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135776/
https://www.ncbi.nlm.nih.gov/pubmed/35471562
http://dx.doi.org/10.1007/s43441-022-00405-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135776/
https://www.ncbi.nlm.nih.gov/pubmed/35471562
http://dx.doi.org/10.1007/s43441-022-00405-0

Ejemplares similares